Hopital Saint Antoine — Clinical Trial Site

152 Registered trials

58 Currently recruiting

Organisation

Hopital Saint Antoine

Location

Paris Cedex 12, France

Identifier

ORG-100028393

Address

184 Rue Du Faubourg Saint Antoine, 75571, France

Departments

#1300: Cardiology
#3309:Cardiology
2412: Cardiology
3005: Service de Rhumatologie
33002: Oncologie Medicale - Cancerolo
3309, cardiology
7002:Service de Rhumatologie
75
75012
CARDIOLOGY
Chirurgie digestive
Chirurgie Générale et Digestive
Clinical Hematology
Département d'Hématologie
Département d'hématologie et de thérapie Cellulaire
Department of Clinical Hematology and Cell Therapy
Department of Hematology
Emergency
FMT reference center (Gastro-enterology)
FR10019: Hématologie Et De Thérapie Cel
gastro enterology
Gastro-enterology
GASTROENTEROLOGIE
Gastroenterologie et nutrition
Gastroenterology
Gastroenterology and nutrition
General surgery
Hématologie
Hématologie clinique et Therapie cellulaire
Hematologie-Recherche Clinique
hematology
Hematology and Cellular Therapy
Hematology Department
Hépato-Gastro-Entérologie
Hépato-Gastroentérologie
Hepato-gastroenterology
hepatogastroenterologie
Hepatogastroenterology
Hépatologie
hepatology
Hepatology Department
Infectious and Tropical Diseases
Infectious Diseases
Infectious Diseases Unit
Intensive Care Unit
internal medicine
LRIPH
Maladies Infectieuses
Medecine intensive-reanimation
medecine interne
Medical ICU
Medical Oncology
Medical Oncology Department
N/A
ONCOLOGIE
Oncologie médicale
oncology
Oncology service
Paris
Pôle de référence Hépato-gastro-entérologie et oncologie digestive
Rheumatology
Service Cardiologie
service d`Oncologie Médicale
service d'hématologie
Service d'Hématologie et de Thérapie cellulaire
Service d'hématologie et de thérapie cellulaire, Bâtiment Robert André, 2ème étage
Service d'hématologie et thérapie cellulaire
Service d'hépato-gastro-entérologie
service d'oncologie
Service d'Oncologie Médicale
Service d’Endocrinologie et Laboratoire Commun de Biochimie Génétique Moléculaires
Service d’Hématologie, Centre de référence des Microangiopathies Thrombotiques
Service d’hepathologie
Service d’oncologie digestive
Service d’oncologie medicale
Service de Médecine Interne
Service de Rhumatologie
Service des Maladies Infectieuses
Service des maladies infectieuses et tropicales
Service Gastroenterologie et Nutrition
Service hematologie et Therapie Cellulaire
Service Hematologie Oncologie
Service Hépatologie
Service Oncologie Médicale
Z97FR10007: Service d'Hématologie Clinique et Thérapie Cellulaire

Clinical trials at this site (152)

Search interface

FIRST LINE CHEMOTHERAPY FOR METASTATIC GASTRO ENTERO PANCREATIC NEUROENDOCRINE CARCINOMA Recruiting

2024-515300-39-00 METASTATIC GRADE 3 POORLY DIFFERENTIATED NEUROENDOCRINE 4 2024-10-18
A Phase 2b Study to Evaluate the Efficacy and Safety of Oral TAK-279 in Subjects with Moderately to Severely Active Crohn’s Disease Recruiting

2023-506704-14-00 Moderately to Severely Active Crohn's Disease 4 2024-09-04
PRODIGE 70 - CIRCULATE - CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II Recruiting

2024-515297-27-00 colon carcinoma 5 2024-08-14
Treatment of microstellite stable metastatic colorectal cancer presenting high immune infiltrate with chemotherapy (XELOX or FOLFOX Bevacizu… Recruiting

2024-515788-73-00 MICROSATELLITE STABLE (MSS) METASTATIC COLORECTAL CANCE 4 2024-07-30
A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on… Recruiting

2022-502135-19-00 Calcific Aortic Valve Stenosis 4 2024-07-18
Immunotherapy with dostarlimab for locally advanced or metastatic cancer (non-colorectal/non-endometrial) with tumor dMMR/MSI Recruiting

2023-505298-34-00 Patients with dMMR/MSI (non-colorectal/non-endometrial) 4 2024-07-18
A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezom… Recruiting

2023-507632-20-00 Multiple Myeloma 5 2024-05-01
A Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician’s Ch… Recruiting

2023-505660-11-00 Cholangiocarcinoma (LTT, 26.0) 5 2024-04-24
Gut microbiome intervention with EXL01 in combination with nivolumab and FOLFOX as first-line treatment for patients with PD-L1 CPS ≥5 metas… Recruiting

2023-506753-38-00 metastatic gastric adenocarcinoma 4 2024-04-16
A randomised phase II placebo-controlled trial of ART plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) vs ART plus… Recruiting

2024-516150-22-00 HIV 4 2024-04-11
FILOCLL015 - GLORIFY - A phase 2 study evaluating the bispecific CD3xCD20 antibody GLOfitamab in combination with rituximab or obinutuzumab … Recruiting

2022-501554-11-00 Patients with previously untreated Richter’s syndrome ( 4 2024-03-21
RECOVERY Recruiting

2023-507441-29-00 Pneumonia 5 2024-02-29
Watch-and-wait strategy to initiate Dostarlimab-based Immunotherapy in localized deficient mismatch repair (dMMR) and/or microsatellite inst… Recruiting

2023-506102-39-00 metastatic gastric cancer 4 2023-12-18
A 24-Month, Multi-Centre, Open Label Phase IV Post Authorisation Efficacy Study to Evaluate the Efficacy, Safety and Immunogenicity of Daily… Recruiting

2022-502950-14-00 Partial Lipodystrophy 6 2023-12-08
Iberdomide Manteinance Versus Lenalidomide Manteinance Therapy Following Autologous Stem Cell Transplant in Participants with NDMM Recruiting

2022-501515-14-00 Newly Diagnosed Multiple Myeloma (NDMM) 5 2023-09-29
FLUCLORIC - Randomized multicentric Phase III study comparing the efficacy of two reduced intensity conditioning regimens (clofarabine/busul… Recruiting

2022-502019-12-00 acute myeloid leukemia 5 2023-09-14
A multi-center randomized, double blinded phase IIb trial evaluating oral pooled fecal microbiotherapy MaaT033 to prevent allogeneic hematop… Recruiting

2022-501831-18-00 Patients with hematologic malignancies and undergoing a 4 2023-09-13
Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB) Recruiting

2024-512759-19-00 first suspected infection with Mycobacterium tuberculos 4 2023-04-20
MagnetisMM-6: A Phase 3 Study of Elranatamab (PF-06863135) + Daratumumab + Lenalidomide Versus Daratumumab + Bortezomib + Lenalidomide + Dex… Recruiting

2024-514139-50-00 Multiple myeloma 5 2022-11-14
CPX-351 versus intensive chemotherapy in patients with de novo intermediate or adverse risk AML stratified by genomics Recruiting

2022-500295-60-00 Acute Myeloid Leukemia 4 2022-09-15
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone versus Lenalidomide Alone in Participants With Newly Dia… Recruiting

2023-510384-36-00 Newly Diagnosed Multiple Myeloma 5 2022-09-13
Study evaluating the tailored management of locally-advanced rectal carcinoma Recruiting

2024-511609-44-00 Rectum cancer 10 2022-02-03
Fecal microbiota transplantation in Crohn’s disease as relay after anti-TNF withdrawal (MIRACLE) Recruiting

2024-511822-30-00 Crohn’s disease 11 2021-09-22
A global study to assess the efficacy and safety of durvalumab in combination with bevacizumab or durvalumab alone in patients with hepatoce… Recruiting

2023-507689-26-00 Histologically or cytologically confirmed Locoregional 5 2019-10-07